News
Co-organizing the grand event, sharing cutting-edge insights. Jinlangbo made its debut at the 2025 China Vitamin Industry Development High-level Forum, delivering a special report
Release time:
2025-12-08
Co-organize the grand event, share the cutting-edge
Jinlangbo made an appearance at the 2025 China Vitamin Industry Development High-Level Forum and delivered a special report
01
Join us for this industry event, where cutting-edge voices capture your attention
From December 3rd to 5th, the 2025 China Vitamin Industry Development High-Level Forum, themed "New Forces Reshaping the Competitive Landscape in the New Cycle", was grandly held in Huayuan Village, Dongyang City, Zhejiang Province, the first "village-based small city" in China. The forum gathered experts and leaders from various sectors including industry, academia, research, and application, engaging in in-depth discussions around industry trends, research progress, and technological innovation. As a co-organizer of the forum, Jinlangbo joined forces with industry colleagues to celebrate this significant event and jointly explore technological innovations and future trends in the vitamin industry.
As a co-organizer of this forum, Jinlangbo was deeply involved in the preparation and exchange work of the conference, actively fulfilling its mission of promoting industry progress. At the highly anticipated special forum, Wang Zhongqiang, the company's technical director, was invited to deliver a special report titled "Quality and Process Evolution of 25-Hydroxyvitamin D3", sharing the company's latest research results and industry insights in the field of 25-hydroxyvitamin D3.
02
In-depth interpretation of quality and process evolution
In the report, Mr. Wang provided an in-depth interpretation from multiple perspectives, including animal health pain points, product value mechanisms, global quality standards, and process routes, which garnered industry attention. The report systematically compared the requirements of mainstream regulations in China, the United States, and Europe regarding the purity, impurities, and residual limits of 25-OHD3. It emphasized that Jingxin's new product had passed testing by a third-party laboratory in the United States, with no detectable key risk substance calcitriol (<1 ppb), demonstrating the company's rigor in quality control. Additionally, it showcased Jingxin's full industrial chain layout in the field of 25-OHD3, covering the complete synthesis pathway from cholesterol, intermediates, to finished products.
03
The exchange yielded fruitful results, consolidating industry ties
During the forum, our company team engaged in extensive and in-depth exchanges with renowned experts and partners from both domestic and international backgrounds. Through technical discussions and industry dialogues, we not only showcased our professional strength in the vitamin field but also further strengthened industry ties, laying a solid foundation for future cooperation.
Through continuous process optimization and rigorous quality control, Jinlangbo provides the industry with more efficient and stable 25-OHD3 solutions, enhancing animal health and breeding efficiency. In the future, Jinlangbo will continue to deepen innovation and drive vitamin nutrition towards precision and greenification.
More news
Address: No. 53 Yulin Road, Yulin Street, Xinchang County, Zhejiang Province
Tel: +86-575-86297308 +86-575-86297565
Fax: 0575-86297657
Email: jinlangbo@jingxinpharm.com